Tag: U.S
‘Groundbreaking HPV Vaccine Research Unveiled by U.S. Scientists’
Alright, so like, this study done by the National Cancer Institute in Chicago shows that using just one dose of the HPV vaccine could be just as effective as using two doses. And apparently,...
US Attempts to Control and Dismantle WHO: A Historical Overview
After the inauguration of the 47th president of the United States, Donald Trump, a controversial decision was made to withdraw the U.S. from the World Health Organization (WHO). This move sparked widespread condemnation from...
Suspend U.S. patents on medicines to fight U.S. tariffs
In the wake of the recent imposition of 25% tariffs on goods from Canada by the Trump administration, the Canadian government is responding with tariffs of its own. Amidst this escalating trade conflict, there...
Zepbound: Eli Lilly’s Obesity Drug Approved for Sleep Apnea Treatment in U.S.
Zepbound: Eli Lilly's Obesity Drug Approved for Sleep Apnea Treatment in U.S.The Food and Drug Administration made a groundbreaking announcement on Friday, granting approval to Eli Lilly's obesity drug, Zepbound, for the treatment of...
Next U.S. Dietary Guidelines: 5 Questions and Impossible Restrictions
The Dietary Guidelines for Americans, which are updated every five years, play a significant role in shaping federal nutritional programs like WIC, school lunches, and meals for veterans and seniors. Despite this, a large...
Impact of U.S. Election on Medicare, Drug Pricing, and AI
Health care is a significant topic in the upcoming U.S. election, with leaders from different political backgrounds sharing their views on various health care issues at STAT's Summit. Among the topics discussed were Medicare,...
U.S. Ranks Last in Health Care Among High-Income Countries: Report
U.S. Health Care Ranks Last Among High-Income Countries: A Comprehensive AnalysisIn a recent report based on tens of thousands of survey responses from primary care physicians and residents in high-income countries over the last...
U.S. Increases ADHD Drug Production Limit to Alleviate Shortage
The Drug Enforcement Administration (DEA) has recently made a significant move to alleviate the ongoing shortage of ADHD medication in the United States by increasing the production limit for Takeda Pharmaceutical’s popular drug Vyvanse...
GLP-1 Weight Loss Drug: Boosting the U.S. Economy
Introduction: The Impact of GLP-1 Weight Loss Drug on the U.S. EconomyThe rise of the GLP-1 weight loss drug has sparked interest not only in the health and wellness industry but also...
J&J Plan to Switch Payments for 340B Hospitals Rejected by U.S. Agency
The U.S. Health Resources and Services Administration has rejected a plan by Johnson & Johnson to change payment methods for hospitals participating in the 340B drug discount program. The agency stated that the proposed...
